Keir Loiacono, JD

Mr. Loiacono brings nearly 20 year of transactional experience from the biotech, pharmaceutical and medtech industries. A patent lawyer by training, Mr. Loiacono represented companies of various sizes in all stages of transactions, including licensing and M & A. As a seasoned life sciences executive in the oncology sector, he has extensive experience raising capital in the public capital market space and closed numerous deals including licenses, clinical collaborations and strategic transactions with significant upfront payments. Prior to being appointed Chief Executive Officer, Mr. Loiacono served as Chief Business Officer for BlueSphere.